overview
CSIR-IGIB, under the leadership of Drs. Souvik Maiti and Debojyoti Chakraborty have developed an indigenous CRISPR-based system for correcting the Sickle Cell Disease (SCD) mutation. Funded by the Ministry of Tribal Affairs and DST, the technology is ready for clinical trials at AIIMS, New Delhi, with technical support provided for clinical-grade material production and licensing.
Photo Gallery
- 6
TRL
- 0
Number of units currently deployed
- 30
No. of days or hours of training required
Get In Touch
For any queries or concerns, please submit your message using the form below. Our team will review your submission and respond at the earliest.
Contact DeveloperDebojyoti Chakraborty CSIR Institute of Genomics and Integrative Biology Email: debojyoti[dot]chakraborty[at]igib[dot]in |
Show your Interest
Last Updated on : 13-April-2026
